These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 375088)

  • 1. Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.
    Herman TS; Einhorn LH; Jones SE; Nagy C; Chester AB; Dean JC; Furnas B; Williams SD; Leigh SA; Dorr RT; Moon TE
    N Engl J Med; 1979 Jun; 300(23):1295-7. PubMed ID: 375088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of the antiemetic effects of nabilone and prochlorperazine on chemotherapy-induced emesis.
    Steele N; Gralla RJ; Braun DW; Young CW
    Cancer Treat Rep; 1980; 64(2-3):219-24. PubMed ID: 6250699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy.
    Markman M; Sheidler V; Ettinger DS; Quaskey SA; Mellits ED
    N Engl J Med; 1984 Aug; 311(9):549-52. PubMed ID: 6379459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.
    Chan HS; Correia JA; MacLeod SM
    Pediatrics; 1987 Jun; 79(6):946-52. PubMed ID: 3035479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nabilone: an effective antiemetic in patients receiving cancer chemotherapy.
    Einhorn LH; Nagy C; Furnas B; Williams SD
    J Clin Pharmacol; 1981; 21(S1):64S-69S. PubMed ID: 6271844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.
    Sallan SE; Cronin C; Zelen M; Zinberg NE
    N Engl J Med; 1980 Jan; 302(3):135-8. PubMed ID: 6985702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nabilone: a potent antiemetic cannabinol with minimal euphoria.
    Herman TS; Jones SE; Dean J; Leigh S; Dorr R; Moon TE; Salmon SE
    Biomedicine; 1977 Dec; 27(9-10):331-4. PubMed ID: 606307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin].
    George M; Pejovic MH; Thuaire M; Kramar A; Wolff JP
    Biomed Pharmacother; 1983; 37(1):24-7. PubMed ID: 6311306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of oral granisetron versus oral prochlorperazine in preventing nausea and emesis in patients receiving moderately emetogenic chemotherapy.
    Burris H; Hesketh P; Cohn J; Moriconi W; Ryan T; Friedman C; Fitts D
    Cancer J Sci Am; 1996; 2(2):85-90. PubMed ID: 9166505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol.
    Ekert H; Waters KD; Jurk IH; Mobilia J; Loughnan P
    Med J Aust; 1979 Dec; 2(12):657-9. PubMed ID: 231736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
    Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
    N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
    Citron ML; Herman TS; Vreeland F; Krasnow SH; Fossieck BE; Harwood S; Franklin R; Cohen MH
    Cancer Treat Rep; 1985 Jan; 69(1):109-12. PubMed ID: 2981616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.
    Sallan SE; Zinberg NE; Frei E
    N Engl J Med; 1975 Oct; 293(16):795-7. PubMed ID: 1099449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized, double-blind, cross-over study comparing prochlorperazine and lorazepam with high-dose metoclopramide and lorazepam for the control of emesis in patients receiving cytotoxic chemotherapy.
    Bishop JF; Wolf M; Matthews JP; Scott K; Ackland S; Yuen K; Morton C; Hillcoat BL; Cooper IA
    Cancer Treat Rep; 1987 Nov; 71(11):1007-11. PubMed ID: 3315193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydrocannabinol vs. prochlorperazine. The effects of two antiemetics on patients undergoing radiotherapy.
    Ungerleider JT; Andrysiak TA; Fairbanks LA; Tesler AS; Parker RG
    Radiology; 1984 Feb; 150(2):598-9. PubMed ID: 6318262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nabilone in the management of prochlorperazine resistant cancer chemotherapy induced emesis.
    Niamatali C; Fallon SD; Egan EL
    Ir Med J; 1984 Sep; 77(9):276-7. PubMed ID: 6090342
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-blind multiple-dose crossover study of the antiemetic effect of intramuscular levonantradol compared to prochlorperazine.
    Sheidler VR; Ettinger DS; Diasio RB; Enterline JP; Brown MD
    J Clin Pharmacol; 1984 Apr; 24(4):155-9. PubMed ID: 6373843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of oral ondansetron and prochlorperazine for preventing nausea and vomiting after moderately emetogenic chemotherapy.
    Kwong WJ; Parasuraman TV
    Pharm Pract Manag Q; 1999 Apr; 19(1):28-41. PubMed ID: 10351607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiemetic effect of perphenazine versus prochlorperazine intravenously before cisplatin therapy.
    Smaglia RA; Parkinson DR; Taylor CD
    Clin Pharm; 1984; 3(1):68-71. PubMed ID: 6365417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind crossover trial of droperidol, metoclopramide, and prochlorperazine as antiemetics in cisplatin therapy.
    Lewis GO; Bernath AM; Ellison NM; Gallagher JG; Porter PA; Rine KT
    Clin Pharm; 1984; 3(6):618-21. PubMed ID: 6391784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.